Trademark Search in Canada

VIMBIETO

View On IC.GC.CA

APPROVED

on 7 Feb 2025

Last Applicant/ Owned by

Bayer Intellectual Property GmbH

Alfred-Nobel-Str. 5040789 Monheim am Rhein

Serial Number

2237237 filed on 10^th Jan 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

VIMBIETO

Trademark usage description

pharmaceutical preparations for the treatment of gynecological diseases, namely, gynecologic cancer, endometrial hyperplasia, endometriosis, endometr Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of gynecological diseases, namely, gynecologic cancer, endometrial hyperplasia, endometriosis, endometritis, menstrual disorders and menopausal vasomotor symptoms (VMS) to decrease night sweats and hot flashes and improve sleep quality; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of oncological diseases.

Classification kind code

Mark Details

Serial Number

2237237

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 10^th May 2024	Agent Changed
Submitted for opposition 22 on 3^rd May 2024	Search Recorded
Submitted for opposition 20 on 3^rd May 2024	Examiner's First Report
Submitted for opposition 223 on 3^rd May 2024	Total Provisional Refusal
Submitted for opposition 256 on 4^th Dec 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 2^th Feb 2023	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 1^st Feb 2023	Created
Submitted for opposition 31 on 1^st Feb 2023	Formalized
Submitted for opposition 30 on 10^th Jan 2023	Filed
Submitted for opposition 228 on 10^th Jan 2023	International Registration